Designation expands the availability of Tasso's patient-centric blood collection solution for decentralized clinical trials, home diagnostic testing, wellness and anti-doping uses to the European ...

Athletes may be asked if they would like to participate in a trial of the new Tasso+ in addition to the intravenous blood sample they are already required to provide Participation is voluntary, but ...

Tasso received FDA 510(k) clearance for its patch-like blood collection device, the Tasso+. The device includes a lancet, which adheres to the arm, that connects to a test tube for collection. After ...

SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of convenient, clinical-grade blood collection solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared its ...

Tasso has taken a major step forward in its plans to make quick, easy and widespread blood tests a reality, with an FDA clearance for its simple sample collection device. The Tasso+ lancet can be ...

Tasso has partnered with women's healthcare company SheMed to offer at-home blood testing for weight loss treatments in the UK. This collaboration aims to personalise glucagon-like peptide-1 (GLP-1) ...

UK-based blood testing company Thriva has joined forces with medical device manufacturer Tasso to use their innovative blood testing technology to tackle needle phobia, a condition that affects at ...

Neurogen Biomarking has entered a collaboration to adopt Tasso’s needle-free blood collection technology into its at-home Alzheimer’s testing platform. The collaboration will see Neurogen's brain ...

SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric clinical-grade blood collection solutions, today announced it received CE Mark certification for its Tasso+™ device, a ...

Designation expands the availability of Tasso’s patient-centric blood collection solution for decentralized clinical trials, home diagnostic testing, wellness and anti-doping uses to the European ...